A carregar...
APDL1-CART cells exhibit strong PD-L1-specific activity against leukemia cells
Chimeric antigen receptor (CAR) T cells target specific tumor antigens and lyse tumor cells in an MHC-independent manner. However, the efficacy of CAR-T cell and other cancer immunotherapies is limited by the expression of immune-checkpoint molecules such as programmed death-ligand 1 (PD-L1) on tumo...
Na minha lista:
| Publicado no: | Aging (Albany NY) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7993657/ https://ncbi.nlm.nih.gov/pubmed/33653969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.202578 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|